文献速递临床免疫临床生化

巨生长激素(macro-GH)的患病率与病因学研究

The prevalence and etiology of macro-growth hormone (GH).
PubMed 文献 · Clin Chem Lab Med · 2026-04-13

该研究在1552名妇产科就诊女性中筛选出185例高血清生长激素(GH)患者,采用聚乙二醇(PEG)法和凝胶过滤色谱(GFC)检测巨GH。PEG和GFC初筛发现5例疑似巨GH,但其中4例实为人抗兔IgG抗体干扰,仅1例为抗人GH自身抗体导致的真性巨GH。高GH人群中巨GH患病率为0.54%(1/185)。

要点

  • 高血清GH人群中巨GH患病率极低,为0.54%(1/185)。
  • 免疫分析中PEG法初筛巨GH需警惕人抗兔IgG抗体干扰。
  • 真性巨GH由抗人GH自身抗体引起,该抗体结合22kDa和20kDa GH。

核心结论

  • 报道了一例由抗人GH自身抗体导致的巨GH患者,其患病率远低于巨泌乳素血症。

研究设计与样本

  • 研究纳入1552名妇产科就诊女性,从中选取185例血清GH高浓度患者进行筛查。
  • 采用PEG法和GFC检测巨GH,并通过阻断干扰物实验和125I-GH示踪结合实验分析巨GH性质。

主要发现

  • PEG和GFC初筛发现5例疑似巨GH,其中4例归因于人抗兔IgG抗体干扰,仅1例为真性巨GH。
  • 该例真性巨GH由抗人GH自身抗体引起,该抗体对22kDa GH的亲和力为0.77×10^8 M^-1,对20kDa GH为0.71×10^8 M^-1。
  • 该自身抗体显著结合人22kDa GH和20kDa GH,但不结合其他人类垂体前叶激素、大鼠GH或人绒毛膜促性腺激素。

关键数值与推荐

  • 高血清GH浓度患者中巨GH患病率为0.54%(1/185)。

临床怎么用

  • 对高血清GH患者排查巨GH时,需注意人抗兔IgG抗体可造成假性巨GH结果。
  • 确诊巨GH需结合GFC及抗体结合实验排除分析干扰。

局限性

  • 研究仅纳入妇产科就诊女性,样本来源受限。
  • 巨GH真性病例仅1例,相关抗体特性结论有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Several macro-hormones have been reported to date. Among them, macroprolactinemia is a common cause of hyperprolactinemia. Growth hormone (GH) and prolactin (PRL) are anterior pituitary hormones related by structure and function. The aim of this study was to clarify the prevalence and etiology of macro-GH. METHODS: We examined the sera of 185 patients with high serum GH concentrations among 1,552 females who visited an obstetrics and gynecology hospital. The presence of macro-GH was investigated via the polyethylene glycol (PEG) method and gel filtration chromatography (GFC). Experiments using several reagents to block interfering substances in the serum with immunoassays and 125I-GH tracers were performed to examine the nature of macro-GH. RESULTS: PEG and GFC identified five patients with potential macro-GH, but four of them were due to the interference caused by human anti-rabbit IgG antibodies. One patient had true macro-GH due to anti-human GH autoantibody. The prevalence of macro-GH was 0.54 % (1/185) in patients with high serum GH concentrations. A 125I-GH binding study revealed that this autoantibody significantly bound to human 22-kDa GH and 20-kDa GH but did not bind to the other human anterior pituitary hormones, rat GH or human chorionic gonadotropin. The affinity of the anti-GH autoantibody was 0.77 × 108 M-1 for 22-kDa GH and 0.71 × 108 M-1 for 20-kDa GH. CONCLUSIONS: We presented a patient with macro-GH due to anti-human GH autoantibody. The prevalence of macro-GH was extremely rare compared to that of macro-PRL.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Ohno H, Hattori N, Nishiyama N, et al. The prevalence and etiology of macro-growth hormone (GH). Clin Chem Lab Med. 2026. PMID: 41964103. doi:10.1515/cclm-2026-0043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。